BRÈVE

sur HBM Healthcare Investments AG (ETR:CH001262)

HBM Healthcare Reports February 2026 Financial Performance

HBM Healthcare Investments AG released its key financial figures for February 2026. The Net Asset Value (NAV) per share stands at CHF 272.51, marking a monthly decline of 2.7%. Year-to-date, the NAV shows a 14.6% increase. However, the calendar year-to-date performance records a slight decrease of 3.0%.

The company's share price is CHF 220.00 as of mid-February, which is down by 8.3% for the month. Despite this, the share price has increased by 25.7% since the start of the fiscal year. Calendar year-to-date, the share price has seen a marginal decline of 2.9%.

Total net assets are reported at CHF 1,806 million. These figures highlight the mixed performance seen in the healthcare investment sector during this period.

R. E.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de HBM Healthcare Investments AG